Laura Bonmassar

miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A

Simona Caporali, Adriana Amaro, Lauretta Levati et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 83 citations · Full text

Cetuximab ± chemotherapy enhances dendritic cell‐mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen‐specific cytotoxic T‐cell response <i>in vitro</i>

Pierpaolo Correale, Cirino Botta, Maria Grazia Cusi et al. · International Journal of Cancer · 2011 · 74 citations · Full text

Antitumour activity of resveratrol on human melanoma cells: A possible mechanism related to its interaction with malignant cell telomerase

Chiara Platella, Serena Guida, Laura Bonmassar et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2017 · 48 citations

Oncology, Malignant Cell Telomerase, Oncogenic Agent +8

O6-(4-Bromothenyl)guanine (PaTrin-2), a novel inhibitor of O6-alkylguanine DNA alkyl-transferase, increases the inhibitory activity of temozolomide against human acute leukaemia cells in vitro

Mario Turriziani, Patrizia Caporaso, Laura Bonmassar et al. · Pharmacological Research · 2006 · 41 citations

Novel Inhibitor, O6-alkylguanine Dna Alkyl-transferase, Oncogenic Agent +7

Tolerance of human <i>MSH2</i> ^+/− lymphoblastoid cells to the methylating agent temozolomide

Giancarlo Marra, Stefania D’Atri, Chantal Corti et al. · Proceedings of the National Academy of Sciences · 2001 · 39 citations · Full text